Inhibikase Therapeutics, Inc. (IKT)

CIK 1750149 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Inhibikase Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 8, 20268-K0001193125-26-385293
Aug 26, 20268-K0001193125-26-368296
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352638
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097282
Aug 13, 2026SCHEDULE 13G/A0001875620-26-000017
Aug 11, 202610-Q0001193125-26-344707
Aug 11, 2026S-80001193125-26-344775
Aug 11, 20268-K0001193125-26-344623
Jul 31, 202640001231919-26-000815
Jul 31, 202640001193125-26-328467
Jul 31, 2026SCHEDULE 13G/A0001346824-26-000206
Jul 29, 20268-K0001193125-26-323651
Jul 28, 2026SCHEDULE 13G0002012383-26-002526
Jul 23, 20268-K0001193125-26-313400
Jul 17, 202630001231919-26-000769
Jul 17, 2026SCHEDULE 13G0001346824-26-000193
Jul 14, 20268-K0001193125-26-302580
Jun 30, 202640001193125-26-290470
Jun 30, 202640001193125-26-290472
Jun 30, 202640001193125-26-290476
Jun 30, 202640001193125-26-290477
Jun 30, 202640001193125-26-290475
Jun 30, 202640001193125-26-290474
Jun 29, 20268-K0001193125-26-286747
May 15, 2026SCHEDULE 13G/A0001104659-26-062874